Raju Mohan is CEO AND PRESIDENT of Ventyx Biosciences, Inc.. Currently has a direct ownership of 1.68 Million shares of VTYX, which is worth approximately $2.88 Million. The most recent transaction as insider was on Jun 10, 2024, when has been sold 96,778 shares (Common Stock) at a price of $0.2 per share, resulting in proceeds of $19,355. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.68M
0% 3M change
10.72% 12M change
Total Value Held $2.88 Million

Raju Mohan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
BUY
Exercise of conversion of derivative security
$19,355 $0.2 p/Share
96,778 Added 5.46%
1,675,028 Common Stock
Apr 02 2024
SELL
Open market or private sale
$23,284 $5.4 p/Share
4,312 Reduced 0.27%
1,578,250 Common Stock
Mar 28 2024
BUY
Exercise of conversion of derivative security
-
11,843 Added 0.74%
1,582,562 Common Stock
Dec 20 2023
SELL
Open market or private sale
$124,783 $2.12 p/Share
58,860 Reduced 3.61%
1,570,719 Common Stock
Dec 17 2023
BUY
Exercise of conversion of derivative security
-
116,668 Added 6.68%
1,629,579 Common Stock
Oct 05 2023
SELL
Open market or private sale
$873,300 $29.11 p/Share
30,000 Reduced 1.94%
1,512,911 Common Stock
Oct 05 2023
BUY
Exercise of conversion of derivative security
$241,199 $8.04 p/Share
30,000 Added 1.91%
1,542,911 Common Stock
Sep 05 2023
SELL
Open market or private sale
$996,300 $33.21 p/Share
30,000 Reduced 1.94%
1,512,911 Common Stock
Sep 05 2023
BUY
Exercise of conversion of derivative security
$241,199 $8.04 p/Share
30,000 Added 1.91%
1,542,911 Common Stock
Aug 07 2023
SELL
Open market or private sale
$1,023,000 $34.1 p/Share
30,000 Reduced 1.94%
1,512,911 Common Stock
Aug 07 2023
BUY
Exercise of conversion of derivative security
$241,199 $8.04 p/Share
30,000 Added 1.91%
1,542,911 Common Stock
Jul 05 2023
SELL
Open market or private sale
$1,174,200 $39.14 p/Share
30,000 Reduced 1.94%
1,512,911 Common Stock
Jul 05 2023
BUY
Exercise of conversion of derivative security
$239,471 $8.04 p/Share
29,785 Added 1.89%
1,542,911 Common Stock
Jun 05 2023
SELL
Open market or private sale
$1,034,700 $34.49 p/Share
30,000 Reduced 1.94%
1,513,126 Common Stock
May 05 2023
SELL
Open market or private sale
$1,178,400 $39.28 p/Share
30,000 Reduced 1.91%
1,543,126 Common Stock
Apr 10 2023
SELL
Open market or private sale
$268,487 $29.01 p/Share
9,255 Reduced 0.58%
1,573,126 Common Stock
Apr 06 2023
SELL
Open market or private sale
$218,010 $29.01 p/Share
7,515 Reduced 0.47%
1,582,381 Common Stock
Apr 05 2023
SELL
Open market or private sale
$397,561 $30.05 p/Share
13,230 Reduced 0.83%
1,589,896 Common Stock
Dec 22 2022
SELL
Open market or private sale
$1,749,739 $31.61 p/Share
55,354 Reduced 3.34%
1,603,126 Common Stock
Dec 17 2022
BUY
Exercise of conversion of derivative security
-
116,669 Added 6.57%
1,658,480 Common Stock
Dec 05 2022
SELL
Open market or private sale
$661,106 $28.74 p/Share
23,003 Reduced 1.47%
1,541,811 Common Stock
Dec 02 2022
SELL
Open market or private sale
$8,035,682 $29.01 p/Share
276,997 Reduced 15.04%
1,564,814 Common Stock
RM

Raju Mohan

CEO AND PRESIDENT
Encinitas, CA

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX